ipilimumab
bms
['congrat']
tils are being now rejuvenated for immunotherapy! 3 decades of development! amazing results! it is all about perseverance and hard work! congratulations and all investigators and co-authors! #esmo22 
Professor and head of Hematology Sorbonne Univ.; past-president of the EBMT; Chairman of the IACH; Editor in Chief: Bone Marrow Transplant; Clin Hematol Int.